Skip to main content
Log in

Otilonium bromide as spasmolytic during endoscopic retrograde cholangiopancreatography

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Endoscopic retrograde cholangiopancreatography (ERCP) is commonly used in both the diagnosis and the treatment of biliary and pancreatic disorders. The aim of this study is to evaluate the effects of OB usage during ERCP on duodenal motility, the tolerability of the procedure (by patients) and the difficulty of the procedure (by the endoscopist).

Method

The study was conducted in Konya Training and Research Hospital General Surgery Endoscopy Unit in randomized prospective pattern. The patients were divided into the two groups as spasmolytic and control groups. The procedure was performed under topical anesthesia and sedation.

Results

There were 100 cases included into the study (50 cases in each group). The mean duodenal motility score was found to be 1.9 ± 0.5 in the study group and 3 ± 0.6 in the control group. In the study group, the tolerability of the procedure score by the endoscopist was moderate in 16 % and well/very well in 78 % of the cases. On the other hand, in the control group, the scores were poor in 21 %, moderate in 71 %, and well/very well in 24 % of the cases. In terms of patient satisfaction, in study group 42 % of the cases reported the procedure as moderate and 58 % reported as well/very well. However, in the control group 16 % of the cases reported the procedure as poor, 58 % moderate, and 26 % as well/very well.

Conclusion

Otilonium bromide is a safe agent with low side effects. It can be used before the ERCP procedure to decrease the duodenal motility. It eases the procedure, moreover, it increases the patients’ satisfaction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Evangelista S (1999) Otilonium bromide: a Selective spasmolytic for the gastrointestinal tract. J Int Med Res 27:207–222

    CAS  PubMed  Google Scholar 

  2. Strege PR, Evangelista S, Lyford GL, Sarr MG, Farrugıa G (2004) Otilonium bromide inhibits calcium entry through L-type calcium channels in human intestinal smooth muscle. Neurogastroenterol Motil 16:167–173

    Article  CAS  PubMed  Google Scholar 

  3. Spinelli A (2007) Irritable bowel syndrome. Clin Drug Investig 27(1):15–33

    Article  CAS  PubMed  Google Scholar 

  4. Battaglia G, Morselli-Labate AM, Camarri E, Francavilla A, De Marco F, Mastropaolo G, Naccarato R (1998) Otilonium bromide in irritable bowel syndrome: a double-blind, placebo-controlled, 15-week study. Aliment Pharmacol Ther 12(10):1003–1010

    Article  CAS  PubMed  Google Scholar 

  5. Lynch CR, Khandekar S, Lynch SM et al (2007) Sublingual L-hyoscyamine for duodenal antimotility during ERCP: a prospective randomized doubleblinded study. Gastrointest Endosc 66:748–752

    Article  PubMed  Google Scholar 

  6. Hannigan BF, Axon AT, Avery S et al (1982) Buscopan or glucagon for endoscopic cannulation of ampulla of vater? J R Soc Med 75:21–22

    CAS  PubMed Central  PubMed  Google Scholar 

  7. Yamamoto N, Nakai Y, Sasahira N, Hirano K, Tsujino T, Isayama H, Komatsu Y, Tada M, Yoshida H, Kawabe T, Hiki N, Kaminishi M, Kurosaka H, Omata M (2006) Efficacy of peppermint oil as an antispasmodic during endoscopic retrograde cholangiopancreatography. J Gastroenterol Hepatol 21(9):1394–1398

    PubMed  Google Scholar 

  8. Sutton JA, Kilminster SG, Mould GP (1997) The clinical pharmacology of single doses of otilonium bromide in healthy volunteers. Eur J Clin Pharmacol 52(5):365–369

    Article  CAS  PubMed  Google Scholar 

  9. Lazzaroni M, Porro GB (2001) Preparation, premedication, and surveilance. Endoscopy 33(2):103–108

    Article  CAS  PubMed  Google Scholar 

  10. Bell GD (2000) Preparation, premedication, and surveillance. Endoscopy 32(2):92–100

    Article  CAS  PubMed  Google Scholar 

  11. Marshall JB, Patel M, Mahajan RJ, Early DS, King PD, Banerjee B (1999) Benefit of intravenous antispsamodic (hyoscyamine sulfate) as premedication for colonoscopy. Gastrointest Endosc 49:720–726

    Article  CAS  PubMed  Google Scholar 

  12. Gómez NA, León CJ, Gutiérrez J (1997) Use of spasmolytic agent otilonium bromide (spasmomen) in digestive endoscopy: a prospective study in 63 patients. Acta Gastroenterol Latinoam 27(3):123–125

    PubMed  Google Scholar 

Download references

Disclosures

Drs Ömer Karahan, Barış Sevinç, Ahmet Okuş, Serden Ay and Nergis Aksoy have no conflicts of interest and financial ties to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Barış Sevinç.

Additional information

RCT registration ID: AEARCTR-0000429 (registration date: 04.07.2014). The full trial can be found at: http://www.socialscienceregistry.org/trials/429.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Karahan, Ö., Sevinç, B., Okuş, A. et al. Otilonium bromide as spasmolytic during endoscopic retrograde cholangiopancreatography. Surg Endosc 29, 2266–2269 (2015). https://doi.org/10.1007/s00464-014-3939-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-014-3939-2

Keywords

Navigation